Chidziwitso cha pasukulupo ndi chobiriwira: Kuti mudziwe zaposachedwa kwambiri pasukulu ya UMMS, nkhani ndi zothandizira, chonde pitani kumassmed.edu/coronavirus
Monga gawo la pulogalamu ya National Institutes of Health's Rapid Diagnostic Acceleration (RADx), kafukufuku wanthawi yayitali wopangidwa ndi ofufuza ochokera ku University of Massachusetts Medical School adati kuyesa kwa PCR komanso kuyesa kwa antigen mwachangu kwa SARS-CoV-2 ndizothandiza pakuzindikira. matenda Ndi chimodzimodzi ogwira.Perekani kawiri pa sabata.
Malinga ndi kutulutsidwa kwa atolankhani a NIH, ngakhale kuyezetsa kwa PCR kumatengedwa ngati muyezo wagolide, kumakhala kovutirapo kuposa kuyesa kwa antigen, makamaka kumayambiriro kwa matenda, koma zotsatira zake zikuwonetsa kuti zikachitika nthawi zonse ngati gawo la pulogalamu yowunika, awiriwa akuwoneka kuti ali ndi kachilomboka. njira zoyesera ndizovuta kwambiri.Kuzindikira kumatha kufika 98%.Iyi ndi nkhani yabwino pamapulogalamu ambiri oletsa kupewa, chifukwa kuyezetsa ma antigen pamalo osamalira kapena kunyumba kumatha kupereka zotsatira zaposachedwa popanda kulembedwa ndi mankhwala ndipo ndi otsika mtengo kuposa kuyezetsa ma laboratory.
Kafukufukuyu adasindikizidwa mu "Journal of Infectious Diseases" pa June 30. Ofufuza ochokera ku yunivesite ya Illinois ku Urbana-Champaign, Johns Hopkins School of Medicine, ndi National Institute of Biomedical Imaging and Bioengineering omwe analemba pepala ili ndi: Pulofesa Wothandizira. wa Mankhwala Laura L. ·Gibson (Laura L. Gibson);Alyssa N. Owens, Ph.D., Wogwirizanitsa Kafukufuku;John P. Broach, MD, MBA, MBA, Pulofesa Wothandizira wa Emergency Medicine;Bruce A. Barton, PhD, Population ndi Pulofesa wa Quantitative Health Sciences;Peter Lazar, wopanga ma database;ndi David D. McManus, MD, Richard M. Haidack Pulofesa wa Zamankhwala, Wapampando wa Zamankhwala ndi Pulofesa.
Dr. Bruce Tromberg, Mtsogoleri wa NIBIB, nthambi ya NIH, adati: "Kuyesa ma antigen mwachangu kunyumba kawiri kapena katatu pa sabata ndi njira yamphamvu komanso yosavuta yoti anthu adziwonetsere kuti ali ndi kachilombo ka COVID-19."Ndikutsegulanso masukulu ndi mabizinesi, chiwopsezo chotenga kachilomboka chimatha kusintha tsiku lililonse.Kuyezetsa ma antigen mosalekeza kungathandize anthu kuthana ndi ngoziyi ndikuchitapo kanthu mwachangu kuti apewe kufalikira kwa kachilomboka. ”
Ofufuzawo adatolera mitundu iwiri ya swabs ndi malovu kwa ogwira nawo ntchito ndi ophunzira omwe atenga nawo gawo pa pulogalamu yowunikira COVID-19 ku University of Illinois ku Urbana-Champaign kwa masiku 14 motsatizana.Imodzi mwamphuno za aliyense wotenga nawo mbali idatumizidwa ku labotale ya Johns Hopkins University kuti akawone kukula kwa kachilomboka pachikhalidwe komanso kuyeza nthawi yomwe mutuwo ungapatsire matendawa kwa ena.
Ofufuzawo adafanizira njira zitatu zodziwira COVID-19: kuyesa kwa PCR yamalovu, kuyesa kwa PCR yamphuno, ndi kuyesa kwapamphuno kwa antigen.Adawerengera kukhudzika kwa njira iliyonse yoyesera kuti azindikire SARS-CoV-2 ndikuyesa kupezeka kwa kachilombo kamoyo mkati mwa milungu iwiri mutadwala.
Ofufuzawo atawerengera kukhudzika kwa mayeso potengera mtundu wa mayeso masiku atatu aliwonse, adanenanso kuti ngakhale atagwiritsa ntchito mayeso othamanga a antigen kapena mayeso a PCR, chidwi chozindikira matenda chinali chachikulu kuposa 98%.Pamene amangoyang'ana maulendo afupipafupi kamodzi pa sabata, kukhudzidwa kwa PCR kudziwika kwa mphuno ndi malovu kunalibe kwakukulu, pafupifupi 98%, koma kukhudzidwa kwa antigen kuzindikira kunatsika mpaka 80%.
"Vuto pakutanthauzira zotsatira za mayeso a PCR kapena antigen ndikuti kuyezetsa kwabwino sikungasonyeze kukhalapo kwa matenda opatsirana (otsika kwambiri) kapena kusazindikira kachilombo kamene kali m'chitsanzo (chochepa kwambiri), motsatana," adatero mtsogoleri wina Dr. Gibson.RADx Tech Clinic Research Chiyambi.
"Kupadera kwa kafukufukuyu ndikuti timaphatikiza PCR ndi kudziwika kwa antigen ndi chikhalidwe cha ma virus ngati chizindikiro chopatsirana.Kapangidwe ka kafukufukuyu kakuwonetsa njira yabwino kwambiri yogwiritsira ntchito mayeso amtundu uliwonse, ndikuchepetsa chiopsezo cha omwe akuganiziridwa kuti ali ndi COVID-19 Wodwalayo amafotokoza zovuta za zotsatira zake. ”
Dr. Nathaniel Hafer, wothandizira pulofesa wa mankhwala a mamolekyu komanso wofufuza wamkulu wa RADx Tech Study Logistics Core, anati: “Monga chitsanzo cha mmene ntchito yathu imakhudzira ntchito yathu, zimene timasonkhanitsa zimathandiza kuti CDC idziwe zambiri zokhudza anthu osiyanasiyana.”
Dr. Hafer adanenanso za udindo waukulu wa UMass School of Medicine popanga, kukhazikitsa ndi kusanthula mayesowa.Iye makamaka anayamikira gulu lofufuza la University of Massachusetts Medical School motsogozedwa ndi Dr. Broach, kuphatikizapo woyang'anira polojekiti Gul Nowshad ndi kafukufuku panyanja Bernadette Shaw-chifukwa cha udindo wawo patali kuyang'ana otenga nawo mbali pa kafukufuku m'chipinda chogona Udindo wofunika pa yunivesite. ku Illinois.
Lipoti logwirizana ndi UMassMed News: Paulendo wa Congress ku kampasi ya NIH, ntchito ya RADx idatsindikitsidwa.UMass Medical School imathandizira kutsogolera NIH RADx kufulumizitsa ukadaulo watsopano woyezetsa COVID.Nkhani Zapamutu: UMass Medical School ilandila thandizo la $ 100 miliyoni la NIH kulimbikitsa kuyezetsa mwachangu, kupezeka kwa COVID-19
Questions or comments? Email: UMMSCommunications@umassmed.edu Tel: 508-856-2000 • 508-856-3797 (fax)
Nthawi yotumiza: Jul-14-2021